Cullinan Oncology, Inc. (CGEM)

NASDAQ: CGEM · IEX Real-Time Price · USD

16.31

-0.42 (-2.51%)

At close: Jul 2, 2024, 4:00 PM

16.49

+0.18 (1.10%)

After-hours: Jul 2, 2024, 5:12 PM EDT

Cullinan Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	940	436	483	674
Market Cap Growth	82.40%	-9.73%	-28.36%	-
Enterprise Value	510	-28	21	384
PE Ratio	-	-2.85	4.34	-10.28
PS Ratio	-	-	-	35.58
PB Ratio	2.21	0.96	0.90	1.59
P/FCF Ratio	-6.04	-3.24	-3.78	-15.52
P/OCF Ratio	-6.04	-3.25	-3.81	-15.52
EV/Sales Ratio	-	-	-	20.25
EV/EBITDA Ratio	-2.08	0.16	0.13	-5.85
EV/EBIT Ratio	-2.08	0.16	0.13	-5.85
EV/FCF Ratio	-2.50	0.20	-0.16	-8.83
Debt / Equity Ratio	0.01	0.01	0.01	-
Debt / EBITDA Ratio	-0.02	-0.02	0.03	-
Debt / FCF Ratio	-0.03	-0.03	-0.04	-
Quick Ratio	19.75	16.60	20.77	24.73
Current Ratio	20.33	17.07	21.09	25.25
Asset Turnover	0	0	0	0.04
Return on Equity (ROE)	-28.70%	-32.10%	20.70%	-14.60%
Return on Assets (ROA)	-27.10%	-30.40%	19.50%	-14.30%
Return on Capital (ROIC)	-39.95%	-41.79%	19.43%	-15.99%
Earnings Yield	-14.08%	-35.13%	23.03%	-9.73%
FCF Yield	-12.93%	-30.85%	-26.45%	-6.44%
Buyback Yield / Dilution	-5.72%	10.91%	-8.27%	-116.61%
Total Shareholder Return	-5.72%	10.91%	-8.27%	-116.61%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).